Re:AlphaFold at CASP13: What just happened?
by dnautics on Monday December 10, 2018 @01:28PM
(#18650018)
While big pharma does do internal r&d, de facto, new drugs and drug strategies largely come by letting the government fund researchers (typically professors at large research institutes), encouraging these professors to do a spin-off (I deliberately don't want to use "startup") to absorb the scientific risk, followed by an acquisition for IP.
Now that Alphabet has sown them a better way, money should pour into the new technique.